REG - Cambridge Cognition - Grant of Options

Cambridge Cognition HoldingsAnnouncement

01/07/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240701:nRSA4662Ua&default-theme=true

RNS Number : 4662U  Cambridge Cognition Holdings PLC  01 July 2024

1 July 2024

 

Cambridge Cognition Holdings plc

("Cambridge Cognition" or the "Company")

 

Grant of Options

 

Cambridge Cognition Holdings plc (AIM: COG), which develops and markets
digital solutions to assess brain health, announces that on 28 June 2024, the
Company granted options (the "Options") over a total of 903,574 ordinary
shares of 1 pence each in the capital of the Company ("Ordinary Shares")
pursuant to the Company's 2022 Long Term Incentive Plan ("LTIP").

 

The Options include:

 

1. Options over 354,421 Ordinary Shares granted to Persons Discharging
Managerial Responsibilities ("PDMRs") as follows:

 

 Name                         Role                      Number of Ordinary Shares over which Options Granted  Total number of Ordinary Shares over which Options held following Grant  Total number of Ordinary Shares held  Percentage of Current Issued Share Capital Held
 Matthew Stork                Chief Executive Officer   192,307                                               1,332,504                                                                223,950                               0.54%
 Alex Livingstone- Learmonth  Chief Commercial Officer  115,384                                               115,384                                                                  10,000                                0.02%
 Ricky Dolphin                Chief Technology Officer  46,730                                                311,589                                                                  120,584                               0.29%

 

2. Options over 549,153 Ordinary Shares granted to other employees of the
Company.

The Options granted to the PDMRs are in each case "performance share awards"
that are exercisable at a price of 1 pence per Ordinary Share from three years
following the date of award until the tenth anniversary of the date of award,
subject to continued service and to the extent to which challenging
performance conditions are achieved.

 

Under the terms of the aforementioned performance conditions, one-half of each
of the Options is subject to sliding scale compound annual growth rate targets
for adjusted revenue over the three year period ending 31 December 2026, the
other half of each of the Options is subject to a sliding scale measure of
relative total shareholder performance over a three year period that commenced
on the grant of the Options.

 

The Options granted to other employees of the Company (save for one more
performance share award) are exercisable at a price of 1 pence per Ordinary
Share from three years following the date of award until the tenth anniversary
of the date of award, and will vest subject to continued service (so called
'restricted share awards').

 

The LTIP has scope to grant both EMI awards and non-EMI awards and was
recently adopted by the Board. The terms of the LTIP align to best practice
expectations, including leaver terms and malus and clawback provisions.

 

Following the grant of Options, the total number of options outstanding over
unissued Ordinary Shares is 3,383,747 representing approximately 8.22% of the
Company's issued share capital.

 

Enquiries

 

 Cambridge Cognition Holdings plc
 Matthew Stork, Chief Executive Officer            Tel: 01223 810 700

 Stephen Symonds, Chief Financial Officer          press@camcog.com (mailto:press@camcog.com)

 Panmure Liberum Limited (NOMAD and Joint Broker)  Tel: 020 78862500
 Freddy Crossley / Emma Earl / Mark Rogers         (Corporate Advisory)
 Rupert Dearden                                    (Corporate Broking)

 Dowgate Capital Limited (Joint Broker)            Tel: 020 3903 7715

 David Poutney/ James Serjeant                     (Corporate Broking)

 Hudson Sandler (Financial PR and IR)              Tel: 020 7796 4133
 Dan de Belder/Hattie Dreyfus

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING
MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM:

 

 1.    Details of the person discharging managerial responsibilities / person closely
       associated
 a)    Names                                                        Matthew Stork - Chief Executive Officer

                                                                    Alex Livingstone - Learmonth - Chief Commercial Officer

                                                                    Ricky Dolphin - Chief Technology Officer
 2.    Reason for the Notification
 a)    Position/status                                              See 1(a) above for positions - all classified as PDMRs of the Company
 b)    Initial notification/ Amendment                              Initial Notification
 3.    Details of the issuer, emission allowance market participant, auction
       platform, auctioneer or auction monitor
 a)    Name                                                         Cambridge Cognition Holdings plc
 b)    LEI                                                          213800SZKDIN122EPA96
 4.    Details of the transaction(s): section to be repeated for (i) each type of
       instrument; (ii) each type of transaction; (iii) each date; and (iv) each
       place where transactions have been conducted
 a)    Description of the Financial instrument, type of instrument  In each case, the grant of Options over Ordinary Shares on 28 June 2024

       Identification code                                          GB00B8DV9647
 b)    Nature of the transaction                                    Grant of Options over Ordinary Shares each with an exercise price of 1 pence
                                                                    per Ordinary Share

 c)    Price(s) and volume(s)                                       Price: n/a

                                                                    Volumes:

                                                                    Matthew Stork - Options over 192,307 Ordinary Shares

                                                                    Alex Livingstone-Learmonth - Options over 115,384 Ordinary Shares

                                                                    Ricky Dolphin -   Options over 46,730 Ordinary Shares
 d)    Aggregated information:

·       Aggregated volume                                   354,421

n/a
       ·       Price
 e)    Date of the transaction                                      28 June 2024
 f)    Place of the transaction                                     Outside a trading venue

 

About Cambridge Cognition

 

Cambridge Cognition is a technology company marketing digital health products
to better understand, detect and treat conditions affecting brain health. The
Company's software products assess cognitive health in patients worldwide to
improve clinical trial outcomes, identify and stratify patients early and
improve global efficiency in pharmaceutical and healthcare industries.

 

For further information visit www.cambridgecognition.com
(http://www.cambridgecognition.com)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHKVLFLZQLBBBD